An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.
Autorzy:
Li Y; Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Chen JA; Interdepartmental Program in Bioinformatics, University of California Los Angeles, Los Angeles, California, United States of America. Sears RL; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Gao F; Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Klein ED; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Karydas A; Memory and Aging Center/Sandler Neurosciences Center, University of California San Francisco, San Francisco, California, United States of America. Geschwind MD; Memory and Aging Center/Sandler Neurosciences Center, University of California San Francisco, San Francisco, California, United States of America. Rosen HJ; Memory and Aging Center/Sandler Neurosciences Center, University of California San Francisco, San Francisco, California, United States of America. BoxerAL; Memory and Aging Center/Sandler Neurosciences Center, University of California San Francisco, San Francisco, California, United States of America. Guo W; Bioinformatics Division and Center for Synthetic & Systems Biology, TNLIST, Tsinghua University, Beijing, China; Department of Molecular, Cell and Developmental Biology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Pellegrini M; Department of Molecular, Cell and Developmental Biology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Horvath S; Departments of Biostatistics and Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Miller BL; Memory and Aging Center/Sandler Neurosciences Center, University of California San Francisco, San Francisco, California, United States of America. Geschwind DH; Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. Coppola G; Department of Psychiatry and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2014 Mar 06; Vol. 10 (3), pp. e1004211. Date of Electronic Publication: 2014 Mar 06 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Disease-Modifying Treatments for Progressive Supranuclear Palsy.
Autorzy:
Stamelou M; Movement Disorders Clinic Second Department of Neurology Attikon Hospital Kapodistrian University of Athens Athens Greece.; Department of Movement Disorders Hygeia Hospital Athens Greece.; Neurology Clinic Philipps University Marburg Germany. BoxerAL; Memory and Aging Center Department of Neurology University of California San Francisco California USA.
Pokaż więcej
Źródło:
Movement disorders clinical practice [Mov Disord Clin Pract] 2015 Feb 02; Vol. 2 (1), pp. 3-5. Date of Electronic Publication: 2015 Feb 02 (Print Publication: 2015).
Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Autorzy:
Sha SJ; Department of Neurology and Neurological Sciences, Stanford University, 300 Pasteur Drive, Rm A343, Stanford, CA 94305 USA. Ghosh PM; Department of Neurology, University of California, San Francisco, San Francisco, CA USA ; Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA USA. Lee SE; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Corbetta-Rastelli C; Department of Neurology, University of California, San Francisco, San Francisco, CA USA ; Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA USA. Jagust WJ; Department of Neurology, University of California, San Francisco, San Francisco, CA USA ; Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA USA ; Lawrence Berkeley National Laboratory, Berkeley, CA USA. Kornak J; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA USA. Rankin KP; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Grinberg LT; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Vinters HV; Department of Neurology, University of California, Los Angeles, CA USA ; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA USA. Mendez MF; Department of Neurology, University of California, Los Angeles, CA USA. Dickson DW; Department of Laboratory Medicine & Pathology, Mayo Clinic, Jacksonville, FL USA. Seeley WW; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Gorno-Tempini M; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Kramer J; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Miller BL; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. BoxerAL; Department of Neurology, University of California, San Francisco, San Francisco, CA USA. Rabinovici GD; Department of Neurology, University of California, San Francisco, San Francisco, CA USA ; Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA USA ; Lawrence Berkeley National Laboratory, Berkeley, CA USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2015 Mar 02; Vol. 7 (1), pp. 8. Date of Electronic Publication: 2015 Mar 02 (Print Publication: 2015).
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.
Autorzy:
Rojas JC; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Karydas A; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Bang J; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Tsai RM; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Blennow K; Clinical Neurochemistry Laboratory Institute of Neuroscience and Physiology Sahlgrenska Academy at University of Gothenburg Sahlgrenska University Hospital Mölndal Sweden. Liman V; Clinical Neurochemistry Laboratory Institute of Neuroscience and Physiology Sahlgrenska Academy at University of Gothenburg Sahlgrenska University Hospital Mölndal Sweden. Kramer JH; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Rosen H; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Miller BL; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California. Zetterberg H; Clinical Neurochemistry Laboratory Institute of Neuroscience and Physiology Sahlgrenska Academy at University of Gothenburg Sahlgrenska University Hospital Mölndal Sweden; Department of Molecular Neuroscience UCL Institute of Neurology Queen Square London United Kingdom. BoxerAL; Memory and Aging Center Department of Neurology University of California, San Francisco San Francisco California.
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.
Autorzy:
Jaeger PA; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. .; Institute of Chemistry and Biochemistry, Free University Berlin, Berlin, Germany. .; Departments of Bioengineering and Medicine, University of California San Diego, La Jolla, CA, USA. . Lucin KM; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.; Present address: Biology Department, Eastern Connecticut State University, Willimantic, CT, USA. Britschgi M; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.; Present address: Roche Pharma Research and Early Development, NORD DTA, Roche Innovation, Center Basel, Basel, Switzerland. Vardarajan B; Department of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA. Huang RP; RayBiotech, Guangzhou, China.; RayBiotech, Norcrosse, GA, USA. Kirby ED; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Abbey R; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA. BoxerAL; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Farrer LA; Department of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA.; Departments of Neurology, Ophthalmology, Genetics and Genomics, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, MA, USA. Finch N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. Head E; Departments of Pharmacology and Nutritional Sciences and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA. Hofree M; Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA. Huang R; RayBiotech, Guangzhou, China.; RayBiotech, Norcrosse, GA, USA. Johns H; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Karydas A; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Knopman DS; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Loboda A; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA. Masliah E; Department of Pathology, University of California San Diego, La Jolla, CA, USA. Narasimhan R; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Podtelezhnikov A; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA. Pradhan S; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Sun CH; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Younkin SG; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Miller BL; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Ideker T; Departments of Bioengineering and Medicine, University of California San Diego, La Jolla, CA, USA. Wyss-Coray T; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. .; Center for Tissue Regeneration, Repair and Restoration, VA Palo Alto Health Care System, Palo Alto, CA, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2016 Apr 26; Vol. 11, pp. 31. Date of Electronic Publication: 2016 Apr 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.
Autorzy:
Jaeger PA; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. .; Institute of Chemistry and Biochemistry, Free University, Berlin, Berlin, Germany. .; Departments of Bioengineering and Medicine, University of California, La Jolla, San Diego, CA, USA. . Lucin KM; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.; Present address: Biology Department, Eastern Connecticut State University, Willimantic, CT, USA. Britschgi M; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.; Present address: Roche Pharma Research and Early Development, NORD DTA, Roche Innovation, Center Basel, Basel, Switzerland. Vardarajan B; Department of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA. Huang RP; RayBiotech, Guangzhou, China.; RayBiotech, Norcrosse, GA, USA. Kirby ED; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Abbey R; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA. BoxerAL; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Farrer LA; Department of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA.; Departments of Neurology, Ophthalmology, Genetics and Genomics, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, MA, USA. Finch N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. Head E; Departments of Pharmacology and Nutritional Sciences and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA. Hofree M; Department of Computer Science and Engineering, University of California, La Jolla, San Diego, CA, USA. Huang R; RayBiotech, Guangzhou, China.; RayBiotech, Norcrosse, GA, USA. Johns H; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Karydas A; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Knopman DS; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Loboda A; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA. Masliah E; Department of Pathology, University of California, La Jolla, San Diego, CA, USA. Narasimhan R; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Podtelezhnikov A; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA. Pradhan S; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Sun CH; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. Younkin SG; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Miller BL; Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Ideker T; Departments of Bioengineering and Medicine, University of California, La Jolla, San Diego, CA, USA. Wyss-Coray T; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. .; Center for Tissue Regeneration, Repair and Restoration, VA Palo Alto Health Care System, Palo Alto, CA, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2016 May 23; Vol. 11 (1), pp. 42. Date of Electronic Publication: 2016 May 23.
Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.
Autorzy:
Zhang Y; Center for Imaging of Neurodegenerative Diseases, VA Medical Center San Francisco, San Francisco, CA, United States of America.; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States of America. Walter R; Center for Imaging of Neurodegenerative Diseases, VA Medical Center San Francisco, San Francisco, CA, United States of America.; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States of America. Ng P; Center for Imaging of Neurodegenerative Diseases, VA Medical Center San Francisco, San Francisco, CA, United States of America.; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States of America. Luong PN; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Dutt S; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Heuer H; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Rojas-Rodriguez JC; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Tsai R; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Litvan I; Department of Neurosciences, Movement Disorder Center, University of California San Diego, San Diego, CA, United States of America. Dickerson BC; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States of America. Tartaglia MC; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America.; University Health Network and Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, ON, Canada. Rabinovici G; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Miller BL; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Rosen HJ; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America. Schuff N; Center for Imaging of Neurodegenerative Diseases, VA Medical Center San Francisco, San Francisco, CA, United States of America.; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States of America. BoxerAL; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Jun 16; Vol. 11 (6), pp. e0157218. Date of Electronic Publication: 2016 Jun 16 (Print Publication: 2016).
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.
Autorzy:
Binney RJ; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Pankov A; Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco CA USA.; Department of Neurological Surgery University of California, San Francisco San Francisco CA USA. Marx G; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. He X; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. McKenna F; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Staffaroni AM; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Kornak J; Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco CA USA. Attygalle S; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. BoxerAL; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Schuff N; Department of Radiology University of California, San Francisco San Francisco CA USA. Gorno-Tempini ML; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Weiner MW; Department of Radiology University of California, San Francisco San Francisco CA USA. Kramer JH; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Miller BL; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA. Rosen HJ; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco CA USA.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2017 Mar 23; Vol. 7 (4), pp. e00675. Date of Electronic Publication: 2017 Mar 23 (Print Publication: 2017).
Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment.
Autorzy:
Cooper YA; Human Genetics and Genomics Graduate Program University of California Los Angeles Los Angeles California.; Medical Scientist Training Program David Geffen School of Medicine at the University of California Los Angeles Los Angeles California.; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California Los Angeles Los Angeles California. Nachun D; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California Los Angeles Los Angeles California. Dokuru D; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California Los Angeles Los Angeles California. Yang Z; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California Los Angeles Los Angeles California. Karydas AM; Memory and Aging Center Department of Neurology University of California San Francisco San Francisco California. Serrero G; A&G Pharmaceutical, Inc. 9130 Red Branch Rd Columbia Maryland 21045.; Greenebaum Cancer Center University of Maryland Baltimore Maryland 21201. Yue B; Greenebaum Cancer Center University of Maryland Baltimore Maryland 21201. BoxerAL; Memory and Aging Center Department of Neurology University of California San Francisco San Francisco California. Miller BL; Memory and Aging Center Department of Neurology University of California San Francisco San Francisco California. Coppola G; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California Los Angeles Los Angeles California.; Department of Neurology University of California Los Angeles Los Angeles California.
Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers.
Autorzy:
Meeter LHH; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands. Gendron TF; Department of Neuroscience Mayo Clinic Jacksonville Florida. Sias AC; Department of Neurology Memory and Aging Center University of California San Francisco California. Jiskoot LC; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands.; Department of Neurodegenerative Diseases Dementia Research Centre Institute of Neurology University College London WC1N 3BG London United Kingdom.; Department of Radiology Leiden University Medical Center Leiden the Netherlands. Russo SP; Department of Neurology Memory and Aging Center University of California San Francisco California. Donker Kaat L; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands.; Department of Clinical Genetics Leiden University Medical Center Leiden the Netherlands. Papma JM; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands. Panman JL; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands.; Department of Radiology Leiden University Medical Center Leiden the Netherlands. van der Ende EL; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands. Dopper EG; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands. Franzen S; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands. Graff C; Division of Neurogeriatrics Department NVS Karolinska Institutet Center for Alzheimer Research Huddinge 14157 Sweden.; Department of Geriatric Medicine Karolinska Institutet Karolinska University Hospital- Huddinge Stockholm 14186 Sweden. BoxerAL; Department of Neurology Memory and Aging Center University of California San Francisco California. Rosen HJ; Department of Neurology Memory and Aging Center University of California San Francisco California. Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit Department of Neurology Hospital Clínic Institut d'Investigació Biomèdica August Pi i Sunyer Villarroel, 170 Barcelona 08036 Spain. Galimberti D; University of Milan Fondazione Ca' Granda IRCSS Ospedale Policlinico Milan Italy. Pijnenburg YAL; Alzheimer Center and Department of Neurology Amsterdam Neuroscience VU University Medical Center PO Box 7057 Amsterdam 1007 MB the Netherlands. Benussi L; Molecular Markers Laboratory IRCCS Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy. Ghidoni R; Molecular Markers Laboratory IRCCS Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy. Borroni B; Neurology Unit Department of Clinical and Experimental Sciences Centre for Neurodegenerative Diseases University of Brescia Brescia Italy. Laforce R Jr; Département des Sciences Neurologiques Clinique Interdisciplinaire de Mémoire (CIME) CHU de Québec Université Laval Québec Canada. Del Campo M; Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience VU University Medical Center PO Box 7057 Amsterdam 1007 MB the Netherlands. Teunissen CE; Neurochemistry Laboratory Department of Clinical Chemistry Amsterdam Neuroscience VU University Medical Center PO Box 7057 Amsterdam 1007 MB the Netherlands. van Minkelen R; Department of Clinical Genetics Erasmus Medical Center PO Box 2040 Rotterdam 3000 CA the Netherlands. Rojas JC; Department of Neurology Memory and Aging Center University of California San Francisco California. Coppola G; Department of Neurology and Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California 760 Westwood Plaza Los Angeles California. Geschwind DH; Department of Neurology and Department of Psychiatry Semel Institute for Neuroscience and Human Behavior University of California 760 Westwood Plaza Los Angeles California. Rademakers R; Department of Neuroscience Mayo Clinic Jacksonville Florida. Karydas AM; Department of Neurology Memory and Aging Center University of California San Francisco California. Öijerstedt L; Division of Neurogeriatrics Department NVS Karolinska Institutet Center for Alzheimer Research Huddinge 14157 Sweden.; Department of Geriatric Medicine Karolinska Institutet Karolinska University Hospital- Huddinge Stockholm 14186 Sweden. Scarpini E; University of Milan Fondazione Ca' Granda IRCSS Ospedale Policlinico Milan Italy. Binetti G; Molecular Markers Laboratory IRCCS Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy.; MAC Memory Center IRCCS Centro San Giovanni di Dio-Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy. Padovani A; Neurology Unit Department of Clinical and Experimental Sciences Centre for Neurodegenerative Diseases University of Brescia Brescia Italy. Cash DM; Department of Neurodegenerative Diseases Dementia Research Centre Institute of Neurology University College London WC1N 3BG London United Kingdom.; Translational Imaging Group Centre for Medical Image Computing University College London London NW1 2HE United Kingdom. Dick KM; Department of Neurodegenerative Diseases Dementia Research Centre Institute of Neurology University College London WC1N 3BG London United Kingdom. Bocchetta M; Department of Neurodegenerative Diseases Dementia Research Centre Institute of Neurology University College London WC1N 3BG London United Kingdom. Miller BL; Department of Neurology Memory and Aging Center University of California San Francisco California. Rohrer JD; Department of Neurodegenerative Diseases Dementia Research Centre Institute of Neurology University College London WC1N 3BG London United Kingdom. Petrucelli L; Department of Neuroscience Mayo Clinic Jacksonville Florida. van Swieten JC; Alzheimer Center Rotterdam and Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam the Netherlands.; Department of Clinical Genetics VU University Medical Center PO Box 7057 Amsterdam 1007 MB the Netherlands. Lee SE; Department of Neurology Memory and Aging Center University of California San Francisco California.
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Autorzy:
Chen JA; Interdepartmental Program in Bioinformatics, University of California, Los Angeles, CA, 90095, USA. Chen Z; Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London, London, SE5 9RX, UK. Won H; Program in Neurogenetics, Department of Neurology and Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. Huang AY; Interdepartmental Program in Bioinformatics, University of California, Los Angeles, CA, 90095, USA. Lowe JK; Program in Neurogenetics, Department of Neurology and Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. Wojta K; Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, 90095, USA. Yokoyama JS; Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, 94158, USA. Bensimon G; BESPIM, CHU-Nîmes, Nîmes, France.; Dept Pharmacologie Clinique, Pitié-Salpêtrière Hospital, AP-PH, Paris, France.; Pharmacology UPMC-Paris VI, Universite Paris-Sorbonne, Paris, France. Leigh PN; Trafford Centre for Biomedical Research, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, UK. Payan C; BESPIM, CHU-Nîmes, Nîmes, France.; Dept Pharmacologie Clinique, Pitié-Salpêtrière Hospital, AP-PH, Paris, France. Shatunov A; Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London, London, SE5 9RX, UK. Jones AR; Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London, London, SE5 9RX, UK. Lewis CM; Medical Research Council Social, Genetic and Developmental Psychiatry Centre, and Department of Medical and Molecular Genetics, King's College London, London, SE5 8AF, UK. Deloukas P; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. Amouyel P; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factor and molecular determinants of aging diseases, Labex-Distalz, F-59000, Lille, France. Tzourio C; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, F-33000 Bordeaux, France. Dartigues JF; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, F-33000 Bordeaux, France. Ludolph A; Department of Neurology, University of Ulm, Oberer Eselsberg, Ulm, Germany. BoxerAL; Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, 94158, USA. Bronstein JM; Program in Neurogenetics, Department of Neurology and Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. Al-Chalabi A; Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King's College London, London, SE5 9RX, UK. Geschwind DH; Interdepartmental Program in Bioinformatics, University of California, Los Angeles, CA, 90095, USA.; Program in Neurogenetics, Department of Neurology and Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. Coppola G; Interdepartmental Program in Bioinformatics, University of California, Los Angeles, CA, 90095, USA. .; Program in Neurogenetics, Department of Neurology and Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. .; Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, 90095, USA. .; Departments of Psychiatry and Neurology, David Geffen School of Medicine, University of California, Los Angeles, 695 Charles E Young Dr. South, Gonda Bldg, Rm 1524, Los Angeles, CA, 90095, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2018 Aug 08; Vol. 13 (1), pp. 41. Date of Electronic Publication: 2018 Aug 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ljubenkov PA; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Staffaroni AM; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Rojas JC; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Allen IE; Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California. Wang P; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Heuer H; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Karydas A; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Kornak J; Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California. Cobigo Y; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Seeley WW; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Grinberg LT; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Spina S; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Fagan AM; Department of Neurology Washington University St. Louis Missouri. Jerome G; Department of Neurology Washington University St. Louis Missouri. Knopman D; Department of Neurology Mayo Clinic Rochester Minnesota. Boeve BF; Department of Neurology Mayo Clinic Rochester Minnesota. Dickerson BC; Frontotemporal Dementia Unit Department of Neurology Massachusetts Alzheimer's Disease Research Center Harvard Medical School, Boston Boston Massachusetts. Kramer J; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Miller B; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. BoxerAL; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California. Rosen HJ; Department of Neurology Memory and Aging Center University of California, San Francisco San Francisco California.
F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.
Autorzy:
Tsai RM; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. . Bejanin A; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Lesman-Segev O; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. LaJoie R; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Visani A; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Bourakova V; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. O'Neil JP; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, USA. Janabi M; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, USA. Baker S; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, USA. Lee SE; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Perry DC; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Bajorek L; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Karydas A; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Spina S; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Grinberg LT; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Seeley WW; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Ramos EM; Departments of Psychiatry and Neurology, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Coppola G; Departments of Psychiatry and Neurology, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Gorno-Tempini ML; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Miller BL; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Rosen HJ; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Jagust W; Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, USA.; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, USA. BoxerAL; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA. Rabinovici GD; Memory and Aging Center, University of California at San Francisco, 675 Nelson Rising Lane, Suite 190, San Francisco, CA, USA.; Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Jan 31; Vol. 11 (1), pp. 13. Date of Electronic Publication: 2019 Jan 31.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Review: Fluid biomarkers for frontotemporal dementias.
Autorzy:
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK. van Swieten JC; Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. BoxerAL; Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA. Rohrer JD; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
Autorzy:
Duff K; a Department of Neurology , University of Utah , Salt Lake City , UT, USA. McDermott D; b Memory and Aging Center, Department of Neurology , University of California , San Francisco , CA, USA. Luong D; b Memory and Aging Center, Department of Neurology , University of California , San Francisco , CA, USA. Randolph C; c Department of Neurology , Loyola University Medical Center , Maywood , IL, USA. BoxerAL; b Memory and Aging Center, Department of Neurology , University of California , San Francisco , CA, USA.
Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy.
Autorzy:
Chen X; Gladstone Institute of Neurological Disease, University of California, San Francisco, CA, 94158, USA. .; Department of Neurology, University of California, San Francisco, CA, 94158, USA. . Li Y; Gladstone Institute of Neurological Disease, University of California, San Francisco, CA, 94158, USA. Wang C; Gladstone Institute of Neurological Disease, University of California, San Francisco, CA, 94158, USA.; Department of Neurology, University of California, San Francisco, CA, 94158, USA. Tang Y; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, 94158, USA. Mok SA; Institute for Neurodegenerative Disease, Department of Pharmaceutical Chemistry, Weill Institute for Neurosciences, University of California, San Francisco, CA, 94158, USA. Tsai RM; Department of Neurology, University of California, San Francisco, CA, 94158, USA.; Memory and Aging Center, University of California, San Francisco, CA, 94158, USA. Rojas JC; Department of Neurology, University of California, San Francisco, CA, 94158, USA.; Memory and Aging Center, University of California, San Francisco, CA, 94158, USA. Karydas A; Department of Neurology, University of California, San Francisco, CA, 94158, USA.; Memory and Aging Center, University of California, San Francisco, CA, 94158, USA. Miller BL; Department of Neurology, University of California, San Francisco, CA, 94158, USA.; Memory and Aging Center, University of California, San Francisco, CA, 94158, USA. BoxerAL; Department of Neurology, University of California, San Francisco, CA, 94158, USA.; Memory and Aging Center, University of California, San Francisco, CA, 94158, USA. Gestwicki JE; Institute for Neurodegenerative Disease, Department of Pharmaceutical Chemistry, Weill Institute for Neurosciences, University of California, San Francisco, CA, 94158, USA. Arkin M; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, 94158, USA. Cuervo AM; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.; Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. Gan L; Gladstone Institute of Neurological Disease, University of California, San Francisco, CA, 94158, USA. .; Department of Neurology, University of California, San Francisco, CA, 94158, USA. .; Helen and Robert Appel Alzheimer's Disease Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10065, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2020 Jan 06; Vol. 15 (1), pp. 2. Date of Electronic Publication: 2020 Jan 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.
Autorzy:
Liu AJ; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Chang JE; Department of Psychological Services, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA. Naasan G; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. BoxerAL; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Miller BL; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Spina S; Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Pokaż więcej
Źródło:
Neurocase [Neurocase] 2020 Apr; Vol. 26 (2), pp. 91-97. Date of Electronic Publication: 2020 Feb 23.
Typ publikacji:
Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy.
Autorzy:
VandeVrede L; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Dale ML; OHSU Parkinson Center and Movement Disorder Program, Department of Neurology Oregon Health and Science University Portland, Oregon USA. Fields S; Department of Pharmaceutical Services University of California San Francisco California USA. Frank M; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Hare E; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Heuer HW; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Keith K; OHSU Parkinson Center and Movement Disorder Program, Department of Neurology Oregon Health and Science University Portland, Oregon USA. Koestler M; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Ljubenkov PA; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. McDermott D; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Ohanesian N; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Richards J; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Rojas JC; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Thijssen EH; Memory and Aging Center, Department of Neurology University of California San Francisco California USA.; Neurochemistry Laboratory, Department of Clinical Chemistry VU University Medical Center Amsterdam The Netherlands. Walsh C; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Wang P; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Wolf A; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. Quinn JF; OHSU Parkinson Center and Movement Disorder Program, Department of Neurology Oregon Health and Science University Portland, Oregon USA. Tsai R; Memory and Aging Center, Department of Neurology University of California San Francisco California USA. BoxerAL; Memory and Aging Center, Department of Neurology University of California San Francisco California USA.
Pokaż więcej
Źródło:
Movement disorders clinical practice [Mov Disord Clin Pract] 2020 Apr 10; Vol. 7 (4), pp. 440-447. Date of Electronic Publication: 2020 Apr 10 (Print Publication: 2020).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies